Skip to Main Content

Paper Details

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Nat Commun
60
2016
19p13, 3'-, ABHD8, ADHD8, ADHD8 promoter, ANKLE1, ANKLE1 3'-, BC, BRCA1, BRCA1 mutation, BRCA1-associated BC, ER, ER-negative BC, OC, SNPs, UTR SNP, breast, breast and ovarian cancer, breast cancer, breast-ovarian cancer, breast-ovarian cancer susceptibility locus, candidate target genes, luciferase, mRNA, ovarian cancer, pleiotropic risk alleles, rs56069439, serous OC, triple negative
Author NameAffiliation
Jonathan TyrerUniversity of Cambridge
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Susan J RamusKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Susan J RamusKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Qiyuan LiMedical College, Xiamen University
Qiyuan LiThe Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Elisa V BanderaRutgers Cancer Institute of New Jersey
Javier Ben??tezSpanish National Cancer Research Centre
Javier Ben??tez
Andrew BerchuckDuke University Medical Center
William J BlotVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
William J BlotInternational Epidemiology Institute
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Anne-Lise B??rresen-DaleK.G. Jebsen Center for Breast Cancer Research, University of Oslo
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Anne-Lise B??rresen-DaleK.G. Jebsen Center for Breast Cancer Research, University of Oslo
Qiuyin CaiVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Ian G CampbellPeter MacCallum Cancer Centre
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Cezary CybulskiPomeranian Medical University
Jennifer A DohertyThe Geisel School of Medicine at Dartmouth
Jennifer A DohertyThe Geisel School of Medicine at Dartmouth
Susan M DomchekAbramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Peter A FaschingUniversity Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN
Peter A FaschingUniversity of California at Los Angeles, David Geffen School of Medicine
Jonine D FigueroaNational Cancer Institute
Jonine D FigueroaNational Cancer Institute
William D FoulkesMcGill University
William D FoulkesMcGill University
Brooke L FridleyUniversity of Kansas Medical Center
Judy E GarberCancer Risk and Prevention Clinic, Dana-Farber Cancer Institute
Montserrat Garcia-ClosasNational Cancer Institute
Montserrat Garcia-ClosasThe Institute of Cancer Research
Montserrat Garcia-ClosasNational Cancer Institute
Montserrat Garcia-ClosasThe Institute of Cancer Research
Aleksandra Gentry-MaharajUCL EGA Institute for Women's Health
Aleksandra Gentry-MaharajUCL EGA Institute for Women's Health
Maya GhoussainiUniversity of Cambridge
Graham G Giles
Graham G GilesThe University of Melbourne
Rosalind GlasspoolCancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre
David E GoldgarHuntsman Cancer Institute, University of Utah School of Medicine
  • 1 - 50

Datasets